Agios Pharmaceuticals Total Current Liabilities

Agios Pharmaceuticals (AGIO) currently reports a total current liabilities of $70M as of June 2026. That compares with $70M in the prior-year period — down 0.3% year over year. Use the charts on this page to explore Agios Pharmaceuticals's total current liabilities history and peer comparisons.

Agios Pharmaceuticals's total current liabilities decreased from $70M to $70M — a 0.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Agios Pharmaceuticals reported $70M in total current liabilities as of June 2026. That compares with $70M in the prior-year period — down 0.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $70M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Agios Pharmaceuticals, and consider following AGIO for alerts when major investors trade the stock.

Agios Pharmaceuticals is classified in the Healthcare sector. On total current liabilities, it currently shows $70M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AGIO with unrelated industries.